Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For GLE.SW
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio inf 0.00 0.39
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 81.64 -37.01 -201.62
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.24 84.42 83.39
Cash -34.04 272.94 413.81
Capex inf 0.00 -8.52
Free Cash Flow inf 0.00 5.31
Revenue -73.92 8.34 31.97
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 0.00 1.00 1.00
Operating Margin 395.71 0.14 0.03
ROA 54.51 < 0.005 < 0.005
ROE 54.93 0.01 < 0.005
ROIC 157.14 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of GLE.SW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of GLE.SW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of GLE.SW is permitted for members.